Use of the energy waveform electrocardiogram to detect subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.

"Declarations Ethics approval and consent to participateBoth studies had obtained ethics approval (LEAVE-DM trial: Alfred Hospital Ethics Committee, ethics approval number HREC/324–19/Alfred-2019; Vic-ELF: Bellberry Limited, ethics approval number 2016–10-727) and followed the guidelines outlined in the Declaration of Helsinki and the National Statement on Ethical Conduct in Human Research. Written informed consent was provided by participants from the LEAVE-DM and Vic-ELF studies. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding T.H.M. is supported by an Investigator grant from the National Health and Medical Research Council, Canberra, Australia (2008129)."

"Trial registration LEAVE-DM, ACTRN 12619001393145 and Vic-ELF, ACTRN 12617000116325"